DERMATROL

Welcome to the Brand page for “DERMATROL”, which is offered here for Transdermal patches for use in the treatment of disorders of the central nervous system, emesis, cancer, endocrine disorders, metabolic disorders, and cardiovascular disorders;.

Its status is currently believed to be active. Its class is unavailable. “DERMATROL” is believed to be currently owned by “SUPERNUS PHARMACEUTICALS, INC.”

Owner:
SUPERNUS PHARMACEUTICALS, INC.
Owner Details
Description:
Transdermal patches for use in the treatment of disorders of the central nervous system, emesis, cancer, endocrine disorders, metabolic disorders, and cardiovascular disorders;
Categories: TRANSDERMAL PATCHES USE